<ѻý>More Evidence That Fenofibrate Slows Diabetic Eye Diseaseѻý> Significant decline in progression to vision-threatening status, proliferative retinopathy Apr 26, 2022
<ѻý>Insulin Glargine Recall; Obesity & Endometrial Cancer; Red Light for Testosterone?ѻý> News and commentary from the endocrinology world Apr 20, 2022
<ѻý>How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease?ѻý> Study finds estimated annual progression rate to diabetes of 5.3% Apr 20, 2022
<ѻý>Who Is Really Driving Up Insulin Costs?ѻý> More attention needs to focus on pharmaceutical middlemen Apr 18, 2022
<ѻý>In Type 2 Diabetes, Metabolic Control Could Add Years to Lifeѻý> Controlling four biomarkers could add as much as a decade to life expectancy Apr 18, 2022
<ѻý>The Winners and Losers of the Proposed Insulin Cost Capѻý> While it benefits some, the $35 cap is only a stopgap measure Apr 08, 2022
<ѻý>Which Anticonvulsant Mood Stabilizer Upped Diabetes Risk?ѻý> Observational study looked at 5-year risk differences between four agents Apr 06, 2022
<ѻý>Cannabis-Exposed Babies Face Poorer Metabolic Healthѻý> By age 5, fat mass and glucose levels show the impact Mar 31, 2022
<ѻý>GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?ѻý> Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
<ѻý>E-Cig Use Tied to Higher Odds of Prediabetesѻý> As in regular cigarettes, nicotine may play a role, researcher says Mar 03, 2022
<ѻý>More Positive Imcivree Data; ICER Reviews Tirzepatide; SGLT2 Inhibitors for Syncope?ѻý> News and commentary from the endocrinology world Feb 20, 2022
<ѻý>Gastric Bypass Most Cost-Effective for Severe Obesity, T2D?ѻý> Modeling study compares Roux-en-Y, conventional medical therapy, and sleeve gastrectomy Feb 14, 2022
<ѻý>FDA OKs 180-Day Implantable Continuous Glucose Monitorѻý> Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
<ѻý>Novel Tirzepatide Wins as Insulin Glargine Add-Onѻý> Another trial in the SURPASS clinical program met primary endpoint Feb 08, 2022
<ѻý>100,000 Diabetes Deaths; Light's Effect on Blood Sugar; Wegovy Supply Woes Continueѻý> News and commentary from the endocrinology world Feb 06, 2022
<ѻý>Warning Labels on Sugary Drinks: Do They Work?ѻý> Randomized trial found picture warning labels turned parents off Feb 01, 2022
<ѻý>Obesity More Common in Type 1 Diabetes Than Expectedѻý> And this is putting the population at a higher risk for chronic kidney disease, researchers say Jan 26, 2022
<ѻý>False Positive COVID Tests; Cannabis and Car Accidentsѻý> Also in TTHealthWatch: diabetes risk among kids with COVID Jan 15, 2022 podcast
<ѻý>Semaglutide vs Liraglutide -- Which Induces More Weight Loss?ѻý> The GLP-1 receptor agonists go head-to-head Jan 11, 2022
<ѻý>Weight-Loss Drug Wegovy Exceeded Expectations, and Supplyѻý> Since its June approval, the injectable flew off shelves and into short supply Dec 29, 2021
<ѻý>Use of GLP-1 Receptor Agonists Scarce in Type 2 Diabetesѻý> Particularly so for racial/ethnic minority populations Dec 17, 2021
<ѻý>Digital HTN, Diabetes Monitoring Program a Boon for Patientsѻý> Program reports growth and better outcomes Dec 09, 2021
<ѻý>Type 1 vs Type 2 Youth-Onset Diabetes: Which Is Worse for the Eyes?ѻý> One type had a higher risk for all diabetes-related ocular complications Dec 02, 2021
<ѻý>Another Study Confirms Gout Benefit With SGLT2 Inhibitorsѻý> Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
<ѻý>Weight Loss Win for Weekly Injections of Novel Amylin Agent in Early Trialѻý> Cagrilintide at least on par with liraglutide after 26 weeks Nov 18, 2021
<ѻý>Blood-Based Biomarkers Prove Mettle in Liver Disease Diagnosisѻý> Data part of initiative to qualify biomarkers to help diagnose fibrosis or NASH Nov 15, 2021
<ѻý>New Jardiance Indication? Bariatric Surgery for NASH; ICER Reviews Tirzepatideѻý> News and commentary from the endocrinology world Nov 14, 2021
<ѻý>More Good News for Empagliflozin in Patients With Heart Failureѻý> Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
<ѻý>Diuretic Bolstered Blood Pressure Control in Advanced CKDѻý> But some safety signals did arise in 12-week trial Nov 05, 2021
<ѻý>Liraglutide After Gastric Bypass Helped Stave Off Weight Regainѻý> The GLP-1 receptor agonist kept patients closer to nadir weight versus lifestyle management alone Nov 04, 2021
<ѻý>Novel Stent Gets 'Sweet' Victory in Diabetes Patientsѻý> SUGAR trial shows superiority of polymer-free stent eluting fatty acid-bound sirolimus Nov 04, 2021
<ѻý>Childhood Obesity Is Soaring to New Levelsѻý> Kids' weight has spiked during the pandemic, but it's part of a long-term trend Oct 30, 2021
<ѻý>No Benefit to Intensifying Diabetes Meds at Hospital Dischargeѻý> Older adults discharged with intensified regimen had higher risk of severe hypoglycemia Oct 21, 2021
<ѻý>Ghrelin Aids Weight Loss; FDA Says Cut Salt; More Bariatric Surgeries With Medicaidѻý> News and commentary from the endocrinology world Oct 17, 2021
<ѻý>Birth Control Pills May Curb PCOS-Related Diabetes Riskѻý> Retrospective results lay groundwork for potential preventive treatment option Oct 14, 2021
<ѻý>FDA Nudges Restaurants, Food Manufacturers to Cut Sodiumѻý> Voluntary guidance aims to reduce Americans' sodium intake by 12% Oct 13, 2021
<ѻý>Bispecific Antibody Compares Favorably With Anti-VEGF for Retinal Diseaseѻý> Similar visual acuity and safety with potential for extended dosing interval Oct 13, 2021
<ѻý>Insulins: Out With the Old, In With the Newѻý> Patients with diabetes embraced insulin analogs, pen-based delivery over 5-year period Oct 12, 2021
<ѻý>Adverse Events Halt Gene Therapy Trial for Diabetic Macular Edemaѻý> Three cases of irreversible vision loss, high rate of intraocular inflammation Oct 12, 2021
<ѻý>Early Steroid Switch May Improve Visual Acuity for Some DME Patientsѻý> Significant improvement in vision, retinal thickening after inadequate response to anti-VEGF Oct 11, 2021